Nina Zila

9PUBLICATIONS
108CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyHaematological tumoursGene and molecular therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 17, 2025
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial).

Julia Maria Ressler, Maud Plaschka, Rita Silmbrod

|Dec 02, 2024
Author Correction: Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment.

Ruoyan Li, Johanna Strobl, Elizabeth F M Poyner

|Nov 18, 2024
Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment.

Ruoyan Li, Johanna Strobl, Elizabeth F M Poyner

|Jun 05, 2024
Off-targets of BRAF inhibitors disrupt endothelial signaling and vascular barrier function.

Sophie Bromberger, Yuliia Zadorozhna, Julia Maria Ressler

|Apr 24, 2024
JAK-STAT signaling maintains homeostasis in T cells and macrophages.

Nikolaus Fortelny, Matthias Farlik, Victoria Fife

|Oct 20, 2023
Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy.

Nina Zila, Ossia M Eichhoff, Irene Steiner

Pageof 2

Frequent Collaborators

3 joint publications

Julia Maria Ressler

3 joint publications

Johanna Strobl

2 joint publications

Philipp Tschandl

2 joint publications

Ossia M Eichhoff